36
Participants
Start Date
April 30, 2013
Primary Completion Date
August 31, 2018
Study Completion Date
August 31, 2018
Calcipotriene 0.005% Foam
All treatments will be administered topically twice daily (morning and evening) for 8 weeks to areas affected with psoriasis (excluding face).
Investigational Site, New York
Investigational Site, Hershey
Philadelphia
Investigational Site, Norfolk
Investigational Site, Winston-Salem
Investigational Site, Chapel Hill
Investigational Site, Alpharetta
Investigational Site, Marietta
Investigational Site, Sandy Springs
Atlanta
Investigational Site, Jacksonville
Miami
Investigational Site, Hollywood
Investigational Site, Miami
Investigational Site, Tampa
Investigational Site, Birmingham
Investigational Site, Plainfield
Investigational Site, Farmington Hills
Investigational Site, Chicago
Investigational Site, St Louis
Investigational Site, St Louis
Saint Joseph
Investigational Site, Rogers
Investigational Site, Houston
Investigational Site, Houston
San Antonio
Investigational Site, Austin
Sherman Oaks
Investigational Site, Encino
Santa Ana
Fountain Valley
Investigational Site, Portland
Investigational Site, Tacoma
Investigational Site, Spokane
Brighton
Investigational Site, Salt Lake City
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Mayne Pharma International Pty Ltd
INDUSTRY